Keyphrases
Acute Myeloid Leukemia
100%
Daunorubicin
100%
P-glycoprotein (P-gp)
100%
Major Vault Protein
100%
Epirubicin Resistance
100%
P. Major
100%
LC50
46%
P-glycoprotein Activity
33%
Steady State
20%
Immunohistochemical Staining
13%
Multidrug Resistance Protein 1 (MDR1)
13%
PSC833
13%
P-glycoprotein Expression
13%
Transport Function
6%
Flow Cytometry
6%
Acute Myeloid Leukemia Cells
6%
Cytotoxicity
6%
Drug Resistance
6%
Drug Efflux
6%
Adult Acute Lymphoblastic Leukemia
6%
Potential Contribution
6%
Multidrug Resistance
6%
Clinical Usefulness
6%
De Novo Acute Myeloid Leukemia
6%
In Vitro Resistance
6%
MTT Assay
6%
P-glycoprotein Inhibitor
6%
Drug Susceptibility Testing
6%
Chemotherapy Failure
6%
Rhodamine 123
6%
Clinical Chemotherapy
6%
Neuroscience
In Vitro
100%
Myeloid
100%
Daunorubicin
100%
ABC Transporter Subfamily B
100%
Lung Resistance Protein
100%
Drug Resistance
12%
Multidrug Resistance Associated Protein 1
12%
Valspodar
12%
Immunocytochemistry
12%
Cytotoxicity
6%
MTT Assay
6%
Flow Cytometry
6%
Biochemistry, Genetics and Molecular Biology
Myeloid
100%
Daunorubicin
100%
P-Glycoprotein
100%
Major Vault Protein
100%
LC50
43%
Steady State
18%
Drug Resistance
12%
Valspodar
12%
Immunocytochemistry
12%
Cytotoxicity
6%
Multidrug Resistance
6%
MTT Assay
6%
Rhodamine 123
6%
Flow Cytometry
6%
Pharmacology, Toxicology and Pharmaceutical Science
Daunorubicin
100%
Acute Myeloid Leukemia
100%
P-Glycoprotein
100%
Lung Resistance Protein
100%
Drug Resistance
12%
Multidrug Resistance Associated Protein 1
12%
Valspodar
12%
Chemotherapy
6%
Flow Cytometry
6%
Effusion
6%
De Novo Acute Myeloid Leukemia
6%
Glycoprotein P Inhibitor
6%
Rhodamine 123
6%
Cytotoxicity
6%
Multidrug Resistance
6%
Immunology and Microbiology
Myeloid
100%
P-Glycoprotein
100%
LC50
53%
Steady State
23%
Drug Resistance
15%
Immunocytochemistry
15%
Leukemia Cell
7%
Cytotoxicity
7%
Multidrug Resistance
7%
Immunology
7%